Varenicline Completed Phase 4 Trials for Smoking / Smoking Behaviors / Cessation, Smoking Treatment

CompletedTreatment4 IdentifierTitleDrugs
NCT04089982Varenicline Light Smoking Pilot
NCT02360631Advancing Tobacco Use Treatment for African American Smokers
NCT02634281Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation?
NCT01836276Understanding Disparities in Quitting in African American and White Smokers
NCT01312909Smoking Cessation Study In Healthy Adolescent Smokers
NCT02562521A Smoking Cessation Intervention for Yale Dining Employees
NCT01474265Sympathovagal Balance in Smoking Cessation
NCT00594204Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking
NCT00691483Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date
NCT00749944Assessing Neuropsychiatric Symptoms Including Depression, Anxiety, Irritability, and Suicidal Thoughts or Behavior in Subjects Quitting Smoking on Varenicline Tartrate or Placebo
NCT00889720A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery
NCT01244061A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider
NCT01456936Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
NCT01639560Varenicline for Light Smokers
NCT02681510UW-CTRI Triple Medication Smoking Cessation Study
NCT00828113Long-term Varenicline Treatment for Smoking Cessation